Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$1.24M Buy
51,100
+50,100
+5,010% +$1.27M ﹤0.01% 3376
2014
Q2
$25K Hold
1,000
﹤0.01% 7792
2014
Q1
$22K Sell
1,000
-65,100
-98% -$1.4M ﹤0.01% 7956
2013
Q4
$1.48M Buy
+66,100
New +$1.46M ﹤0.01% 3125
2013
Q3
Sell
-11,500
Closed -$222K 10506
2013
Q2
$222K Buy
+11,500
New +$240K ﹤0.01% 4982

Other funds holding HOLX

UBS's HOLX Position: Q3 2014 in Review

UBS increased its Hologic (HOLX) stake by 67% in Q3 2014, buying an estimated $1.52M and bringing the position to 149,922 shares worth $3.65M. The position accounts for ﹤0.01% of the portfolio, ranked #2335.

UBS first reported a position in HOLX in Q2 2013 and has held it in 6 quarters since. 353 funds tracked by Wall St. Rank hold HOLX as of Q3 2014.

  • UBS held 149,922 shares of Hologic worth $3.65M as of Q3 2014.
  • UBS bought 60,298 Hologic shares in Q3 2014, an estimated $1.52M.
  • Hologic made up ﹤0.01% of UBS's portfolio in Q3 2014, its #2335 holding.
  • UBS first reported a position in Hologic in Q2 2013 and has held it in 6 quarters since.
  • 353 funds tracked by Wall St. Rank held Hologic as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.